Immunome, Inc. · NASDAQ:IMNM
Vanguard Capital Management LLC reported a 5.04% stake in Immunome, Inc. (Schedule 13G)
Event Sep 30, 2026 · Filed Oct 30, 2026
Vanguard Capital Management LLC reported a 5.04% stake in Immunome, Inc., 5,725,578 shares, as a passive investor on Sep 30, 2026. Filed Oct 30, 2026 (Schedule 13G).
- Stake
- 5.04%
- Shares
- 5,725,578
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Vanguard Capital Management | 5.04% | 5,725,578 |
Source
Download original · View original at SEC
Related
- Immunome, Inc.
- Vanguard Capital Management LLC
- Immunome, Inc. shareholders
- Schedule 13G · Wellington Management Group LLP · Nov 16, 2026
- Form 4 · Higgins Jack · Sep 15, 2026
- Schedule 13G/A · T. Rowe Price Investment Management, Inc. · Aug 14, 2026
- Schedule 13G/A · Sirenia Capital Management LP · Aug 14, 2026
- Form 4 · Barchas Isaac · Aug 12, 2026